Imperial College London Featured PhD Programmes
University of Glasgow Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
University of Liverpool Featured PhD Programmes
University of Surrey Featured PhD Programmes

medicinal PhD Projects, Programs & Scholarships

We have 42 medicinal PhD Projects, Programs & Scholarships

  • "medicinal" ×
  • clear all
Order by 
Showing 21 to 30 of 42
  Activity based proteomic probes for profiling CYP2W1 in cancer tissues
  Research Group: Institute of Cancer Therapeutics
  Dr C Sutton, Dr K Pors
Applications accepted all year round

Funding Type

PhD Type

Cytochromes P450 (CYPs) are a superfamily of mixed function oxidases of which CYP1-4 subfamily members are unique in their ability to oxidise drugs.
  Cytochromes P450 in Cancer: Opportunities for Development of Personalised Medicine
  Research Group: Institute of Cancer Therapeutics
  Dr K Pors, Prof P Loadman
Applications accepted all year round

Funding Type

PhD Type

The improved understanding of cancer biology provides opportunities for the development of molecular targeted therapies.
  Design, synthesis and evaluation of novel polysialyltransferase inhibitors as anti- metastatic agents
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Dr S Shnyder
Applications accepted all year round

Funding Type

PhD Type

Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases (polySTs).
  Development of heterocyclic pharmacophores using diversity-oriented synthesis
  Research Group: Institute of Cancer Therapeutics
  Dr K Pors, Prof L Patterson
Applications accepted all year round

Funding Type

PhD Type

Diversity-oriented synthesis (DOS) is a modern chemical tool, which aims to synthesise small molecules that cover new chemical space with the possibility of finding unexplored biological targets or pathways that may be important for disease progression.
  Polysialyltransferases as a target in metastatic cancer
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Dr S Shnyder
Applications accepted all year round

Funding Type

PhD Type

Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases.
  Tetrazines as Traceless Carriers for Polar Drugs
  Research Group: Medicines Development and Pharmaceutical Sciences
  Dr R Wheelhouse, Prof P Loadman
Applications accepted all year round

Funding Type

PhD Type

A recent invention in Bradford has identified a new carrier molecule that reduces the polarity of polar drugs.
  Natural products in design of new cancer treatments (SEARCEYMU19SF) 
  Prof M Searcey
Application Deadline: 31 May 2019

Funding Type

PhD Type

Natural products are the backbone of clinically used anti-cancer agents and yet suffer from drawbacks associated with their toxicity.
  Targeting the P2X7 purinergic receptor in melanoma (STOKESLU19SF)
  Dr L Stokes, Dr C Morris
Application Deadline: 31 May 2019

Funding Type

PhD Type

There is much research into trying to regain control of cell proliferation or cell death (apoptosis) in cancer. Different strategies exist to do this and a multitude of individual receptor targets are being identified in tumour cell lines and primary cells.
  Small Molecule Signalling in Stem Cell Differentiation
  Dr D France
Applications accepted all year round

Funding Type

PhD Type

Use of stem cells has the potential to transform regenerative medicine, if appropriate strategies can be identified for the controlled differentiation of these progenitors.
  Pre-clinical testing of new therapeutic treatments for cystic kidney disease
  Dr S Bell, Prof C A Johnson
Applications accepted all year round

Funding Type

PhD Type

The primary cilium on the ventral surface of most vertebrate cells acts as an “antennae” that receives and transduces chemo- and mechanosensory signals.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.